0001181431-13-026289.txt : 20130508
0001181431-13-026289.hdr.sgml : 20130508
20130508175344
ACCESSION NUMBER: 0001181431-13-026289
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130506
FILED AS OF DATE: 20130508
DATE AS OF CHANGE: 20130508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wotton Paul K
CENTRAL INDEX KEY: 0001300997
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32302
FILM NUMBER: 13825857
MAIL ADDRESS:
STREET 1: C/O ANTARES PHARMA, INC.
STREET 2: 707 EAGLEVIEW BOULEVARD, SUITE 414
CITY: EXTON
STATE: PA
ZIP: 19341
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANTARES PHARMA, INC.
CENTRAL INDEX KEY: 0001016169
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411350192
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1208
BUSINESS ADDRESS:
STREET 1: 250 PHILLIPS BLVD
STREET 2: SUITE 290
CITY: EWING
STATE: NJ
ZIP: 08618
BUSINESS PHONE: 609-359-3020
MAIL ADDRESS:
STREET 1: 250 PHILLIPS BLVD
STREET 2: SUITE 290
CITY: EWING
STATE: NJ
ZIP: 08618
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20060120
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC
DATE OF NAME CHANGE: 20020520
FORMER COMPANY:
FORMER CONFORMED NAME: ANTARES PHARMA INC /MN/
DATE OF NAME CHANGE: 20010604
4
1
rrd378954.xml
WOTTON MAY 6
X0306
4
2013-05-06
0
0001016169
ANTARES PHARMA, INC.
ATRS
0001300997
Wotton Paul K
C/O ANTARES PHARMA, INC.
100 PRINCETON SOUTH, SUITE 300
EWING
NJ
08628
1
1
0
0
President and CEO
COMMON STOCK
2013-05-06
4
M
0
10000
0.50
A
533547
D
COMMON STOCK
2013-05-06
4
S
0
10000
4.0350
D
523547
D
STOCK OPTION (RIGHT TO BUY)
0.50
2013-05-06
4
M
0
10000
0
D
2018-10-20
COMMON STOCK
10000
1605793
D
The stock option exercises and sales of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The options vested in equal quarterly installments over three years following the grant date.
Robert F. Apple as attorney-in-fact for Paul Wotton
2013-05-08